Search Results

Stroke patients who survive a blood clot in the brain’s blood vessels are prone to developing new blockages during their recovery periods, even if they receive vessel-clearing interventions.
Medicine

Adding Anti-clotting Drugs To Stroke Care Ineffective, Clinical Trial Finds

MBT Desk
4 min read
Medications thought to show promise for stroke did not improve patients’ outcomes
India's First Indigenous Dengue Vaccine Enters Phase 3 Trial: A Major Step in Combating the Disease
Biotechnology

India Launches Phase 3 Clinical Trial for Indigenous Dengue Vaccine - DengiAll

Dr. Pratiksha Jadhav, BDS
3 min read
Groundbreaking Vaccine Trial Aims to Combat Dengue with India's First Homegrown Dengue Vaccine, DengiAll
The companies will not be required to complete the obligatory trials, which usually take a few years, in any of the five categories. (Representational image: Unsplash)
MedBound Blog

India Waives Clinical Trials for Imported Drugs Approved in Key Countries

Priyanka Pandey
2 min read
The Union Health Ministry has made the decision to end the present regulatory procedure of requiring clinical trials for imported medications
The trial's early findings led to the FDA giving the green light to one of the earliest gene therapies for sickle cell disease.
Medicine

Researchers Publish Final Results of Key Clinical Trial for Gene Therapy for Sickle Cell Disease

MBT Desk
3 min read
Preliminary results of the trial led to the FDA approval of one of the first gene therapies for sickle cell disease
In an early phase clinical trial, a combination of antibody-based medications targeting the immune system generated promising safety data and anti-tumor activity in individuals with various types of advanced cancer. (Representational Image: Wikimedia Commons)
Medicine

Clinical Trial Tests Combination Antibody Therapy in Adults with Advanced Cancer

MBT Desk
2 min read
CS1002 plus CS1003 (nofazinlimab) had a manageable safety profile across a broad dosing range and showed promising anti-tumor activity in adults with cancer
AstraZeneca decided to discontinue the clinical trial because the timeline of enrolment is increasing and the event rates are very low in Phase 3 clinical trials for STABILIZE-CKD and DIALIZE, respectively (representational image: Unsplash)
MedBound Blog

AstraZeneca Halts Clinical Trial on Lokelma, a Potassium Reduction Drug for Hyperkalaemia Treatment

MBT Desk
2 min read
AstraZeneca, a biopharmaceutical company, has recently stopped its ongoing clinical trial on Lokelma, a potassium reduction drug that has been approved for treating hyperkalemia.
Read More
logo
Medbound
www.medboundtimes.com